Top Stories
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM

Dr. Reddy's Laboratories expands global presence with Jamaican subsidiary
Dr. Reddy's Laboratories has taken a significant step in its global expansion by establishing a wholly-owned subsidiary in Jamaica. Named “Dr. Reddy’s Laboratories Jamaica Limited”. The Jamaican subsidiary's primary focus will be on pharmaceutical operations, encompassing tasks such as importation, warehousing, distribution, and the export of pharmaceutical products.
Dr. Reddy's Laboratories SA, based in Switzerland and wholly-owned by the parent company, maintains full ownership of this new venture. The subsidiary begins with an authorized capital of $5,000,000, backed by an initial paid-up capital of $3,000,000.
In terms of regulatory compliance, the establishment of the subsidiary adheres to all necessary requirements, having received approvals from the Pharmacy Council of Jamaica. The subsidiary was officially incorporated on September 25, 2023.
Related News

L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr
4 mins read. August 2, 2024 at 12:33 PM
Download app
Access BlinkX
everywhere
across device
